Intra- and inter-individual cognitive variability in schizophrenia and bipolar spectrum disorder: an investigation across multiple cognitive domains

Bibliographic Details
Title: Intra- and inter-individual cognitive variability in schizophrenia and bipolar spectrum disorder: an investigation across multiple cognitive domains
Authors: Beathe Haatveit, Lars T. Westlye, Anja Vaskinn, Camilla Bärthel Flaaten, Christine Mohn, Thomas Bjella, Linn Sofie Sæther, Kjetil Sundet, Ingrid Melle, Ole A. Andreassen, Dag Alnæs, Torill Ueland
Source: Schizophrenia, Vol 9, Iss 1, Pp 1-9 (2023)
Publisher Information: Nature Portfolio, 2023.
Publication Year: 2023
Collection: LCC:Psychiatry
Subject Terms: Psychiatry, RC435-571
More Details: Abstract There is substantial cognitive heterogeneity among patients with schizophrenia (SZ) and bipolar disorders (BD). More knowledge about the magnitude and clinical correlates of performance variability could improve our understanding of cognitive impairments. Using double generalized linear models (DGLMs) we investigated cognitive mean and variability differences between patients with SZ (n = 905) and BD spectrum disorders (n = 522), and healthy controls (HC, n = 1170) on twenty-two variables. The analysis revealed significant case-control differences on 90% of the variables. Compared to HC, patients showed larger intra-individual (within subject) variability across tests and larger inter-individual (between subject) variability in measures of fine-motor speed, mental processing speed, and inhibitory control (SZ and BD), and in verbal learning and memory and intellectual functioning (SZ). In SZ, we found that lager intra -and inter (on inhibitory control and speed functions) individual variability, was associated with lower functioning and more negative symptoms. Inter-individual variability on single measures of memory and intellectual function was additionally associated with disorganized and positive symptoms, and use of antidepressants. In BD, there were no within-subject associations with symptom severity. However, greater inter-individual variability (primarily on inhibitory control and speeded functions) was associated with lower functioning, more negative -and disorganized symptoms, earlier age at onset, longer duration of illness, and increased medication use. These results highlight larger individual differences in patients compared to controls on various cognitive domains. Further investigations of the causes and correlates of individual differences in cognitive function are warranted.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2754-6993
Relation: https://doaj.org/toc/2754-6993
DOI: 10.1038/s41537-023-00414-4
Access URL: https://doaj.org/article/41ec5af73689412a8c314611e049c162
Accession Number: edsdoj.41ec5af73689412a8c314611e049c162
Database: Directory of Open Access Journals
More Details
ISSN:27546993
DOI:10.1038/s41537-023-00414-4
Published in:Schizophrenia
Language:English